검색으로 10,000+ 프로그램 중 최대 5개를 골라 PK/PD · 독성 · 임상을 나란히 비교합니다. · 다음 갱신 D-13 · 마지막 7월 13일
현재 선택: 1개
프로그램 상세에서 관심 등록 후 2개 이상 모으면 여기서 한 번에 비교할 수 있습니다.
표가 넓으면 좌우로 스크롤하세요. 핵심 비교 모드에서는 중요 항목만 표시됩니다.
| 항목 | |
|---|---|
Overview Program | Corticosteroids |
Overview Company | AstraZeneca |
Overview Modality | ANTIBODY |
Overview Target | Acute Lymphoblastic Leukemia (ALL) |
Overview Indication | Lupus Nephritis |
Overview Phase | APPROVED |
Overview Status | ACTIVE |
MoA Mechanism | targeting IL-5 or its receptor |
MoA Biomarker | biomarkers |
PK/PD Species | Rabbit |
PK/PD Animal (cat.) | Unknown |
PK/PD Experiment | PD |
Toxicology Species | Rabbit |
Toxicology Animal (cat.) | Unknown |
Toxicology Major finding | Corticosteroids in asthma and COPD: an inflammopharmacological perspective on molecular and genetic determinants.. Corticosteroids have broad anti-inflammatory effects to treat asthma and COPD. They do not alter the disease's progression, but they do improve the function of lung, symptoms, and quality of life. Additionally, they also reduce the exacerbation of both disorders. In asthma, they reduc… |
Clinical Primary efficacy | 0% |
Clinical ORR | 0% |
Clinical PFS | 51.5 |
Clinical OS | 197 |
Clinical Result source | ClinicalTrials.gov NCT02669914 |
Clinical Data Tier / Score | A · 48 |
Clinical Program phase | APPROVED |
Clinical Clinical sync | 2026년 7월 9일 (5일 전) |
검색으로 10,000+ 프로그램 중 최대 5개를 골라 PK/PD · 독성 · 임상을 나란히 비교합니다. · 다음 갱신 D-13 · 마지막 7월 13일
현재 선택: 1개
프로그램 상세에서 관심 등록 후 2개 이상 모으면 여기서 한 번에 비교할 수 있습니다.
표가 넓으면 좌우로 스크롤하세요. 핵심 비교 모드에서는 중요 항목만 표시됩니다.
| 항목 | |
|---|---|
Overview Program | Corticosteroids |
Overview Company | AstraZeneca |
Overview Modality | ANTIBODY |
Overview Target | Acute Lymphoblastic Leukemia (ALL) |
Overview Indication | Lupus Nephritis |
Overview Phase | APPROVED |
Overview Status | ACTIVE |
MoA Mechanism | targeting IL-5 or its receptor |
MoA Biomarker | biomarkers |
PK/PD Species | Rabbit |
PK/PD Animal (cat.) | Unknown |
PK/PD Experiment | PD |
Toxicology Species | Rabbit |
Toxicology Animal (cat.) | Unknown |
Toxicology Major finding | Corticosteroids in asthma and COPD: an inflammopharmacological perspective on molecular and genetic determinants.. Corticosteroids have broad anti-inflammatory effects to treat asthma and COPD. They do not alter the disease's progression, but they do improve the function of lung, symptoms, and quality of life. Additionally, they also reduce the exacerbation of both disorders. In asthma, they reduc… |
Clinical Primary efficacy | 0% |
Clinical ORR | 0% |
Clinical PFS | 51.5 |
Clinical OS | 197 |
Clinical Result source | ClinicalTrials.gov NCT02669914 |
Clinical Data Tier / Score | A · 48 |
Clinical Program phase | APPROVED |
Clinical Clinical sync | 2026년 7월 9일 (5일 전) |
추천 비교
추천 비교